News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
108last 24h
3128last 7d
512● bullish (7d)
311● bearish (7d)
227publishers
GuruFocus.com2d agobullish
Moderna Inc (MRNA) Q3 2026 Earnings Call Highlights: Revenue Surges 29% as Guidance Raised and ...Investor's Business Daily2d agobullish
Moderna Hits Five-Year High On Sales Beat; But The Real Story Is Still Its Cancer VaccineMT Newswires2d agoneutral
TD Cowen Adjusts Moderna Price Target to $110 From $90, Maintains Hold RatingMT Newswires2d agoneutral
RBC Capital Adjusts Moderna Price Target to $145 From $130, Maintains Sector Perform RatingInvestorsHub2d agobullish
Moderna Shares Jump 10% as Q3 Earnings Beat Forecasts and Revenue Outlook ImprovesBarrons.com2d agoneutral
Moderna Stock Is Up 700% on Cancer Vaccine Hype. Earnings Reveal That Covid Still Counts.The Wall Street Journal2d agoneutral
Moderna Swings to Profit, Lifts Outlook as Covid-19 Vaccine Demand Stabilizes